The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer.
about
Mutations of the EPHB6 receptor tyrosine kinase induce a pro-metastatic phenotype in non-small cell lung cancerDynamic interactions between cancer cells and the embryonic microenvironment regulate cell invasion and reveal EphB6 as a metastasis suppressor.Inhibitory effects of low decibel infrasound on the cardiac fibroblasts and the involved mechanismGenomic aberrations in an African American colorectal cancer cohort reveals a MSI-specific profile and chromosome X amplification in male patients.Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasivenessEphrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survivalIQGAP3 promotes EGFR-ERK signaling and the growth and metastasis of lung cancer cells.Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion.High expression of EphB6 protein in tongue squamous cell carcinoma is associated with a poor outcome.Cardiac peroxisome proliferator-activated receptor-γ expression is modulated by oxidative stress in acutely infrasound-exposed cardiomyocytesEphB6 overexpression and Apc mutation together promote colorectal cancer.EPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells.Targeting synthetic lethality between the SRC kinase and the EPHB6 receptor may benefit cancer treatment.Loss of the EPH receptor B6 contributes to colorectal cancer metastasisPlasma MiRNA alterations between NSCLC patients harboring Del19 and L858R EGFR mutations.EPH-EPHRIN in human gastrointestinal cancersDancing with the dead: Eph receptors and their kinase-null partners.The Eph/Ephrin family in cancer metastasis: communication at the service of invasion.Reduced EphB6 protein in gastric carcinoma and associated lymph nodes suggests EphB6 as a gastric tumor and metastasis inhibitor.Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers.Targeted inhibition of genome-wide DNA methylation analysis in epigenetically modulated phenotypes in lung cancer.Whole genome expression profiling in chewing-tobacco-associated oral cancers: a pilot study.Mutated ephrin receptor genes in non-small cell lung carcinoma and their occurrence with driver mutations-targeted resequencing study on formalin-fixed, paraffin-embedded tumor material of 81 patients.Cancer risk susceptibility loci in a Swedish population.Identification of potentially critical differentially methylated genes in nasopharyngeal carcinoma: A comprehensive analysis of methylation profiling and gene expression profiling.Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis.EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.[DNA methylation and non-small cell lung cancer].[Advances of DNA methylation in lung cancer].
P2860
Q30528942-E85B0D06-BEE5-463C-880C-17CEA249E6ADQ30657415-AB5A34B9-4D65-4887-848A-BF0FB82337B4Q33882685-156B9362-4EEE-44A7-ADC7-0318B33D4B18Q34373935-67485347-7BDB-4FE2-8E61-80C9DFBF619EQ34434924-E4770DB2-9D40-4829-826D-F444BBF4D0F5Q34524860-E57103A3-52FB-4555-91A1-D1162100F9F0Q35172160-86C605F5-A1A9-42C5-A001-5CAA2B6E1883Q36223133-A0E9229F-0077-458A-AC02-A64B2EBF6F5CQ36261833-7CD67862-B55A-4F81-8ED4-E07E4BDB8DFDQ37325731-EF28E3E7-EA90-46C1-9076-5C607874A6A8Q37327672-F80B1F20-4C03-4C82-8ED3-47501D499C45Q37350976-C0242140-5575-4CB3-849E-457941C22E2DQ37580359-527643C0-AB7D-4C60-8137-E8BF9BF1EA16Q37681807-4D4D23FB-E05E-4DE3-A556-86E6B4AF16D7Q37688169-5A7BA2FC-C8AB-4B08-8463-3EC732BF7C2FQ37824603-523D2E9F-A173-43E1-BC92-7E02931A083DQ37860149-92B76F69-845B-4ECB-A216-01092F3C11D0Q38006838-1CB8702E-4D65-44E6-8C07-41855B5EFD65Q38814701-857303DD-DACA-4651-AF3E-A6CDB4D87675Q38831868-1E2F084B-BB63-4236-97C0-B13439E0DBC5Q38880716-15FCF3E1-7061-4120-BE61-37F7CA6886AFQ41462715-F1EE1117-0F21-41D4-8CA4-9DAB0B73EC38Q45907873-B3C45567-5205-41A0-88D8-F5F8FCC05350Q47159601-AFE60008-F047-42C1-8C00-72A48363479BQ49986892-78BB1A7C-4CF1-4341-AD50-B0AFF3FDE15FQ50454825-D4C4EE7A-90D7-4DD6-B20E-F4550A405C53Q52560135-C6E2291C-68A2-42FC-B444-B20AB313091FQ55424890-7D648650-C5FA-4A1E-86A0-FC68F6E9A7D6Q55426266-630A63C9-FABC-4EEB-9420-EDAD3AB03963
P2860
The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The EPHB6 receptor tyrosine ki ...... in non-small cell lung cancer.
@en
The EPHB6 receptor tyrosine ki ...... in non-small cell lung cancer.
@nl
type
label
The EPHB6 receptor tyrosine ki ...... in non-small cell lung cancer.
@en
The EPHB6 receptor tyrosine ki ...... in non-small cell lung cancer.
@nl
prefLabel
The EPHB6 receptor tyrosine ki ...... in non-small cell lung cancer.
@en
The EPHB6 receptor tyrosine ki ...... in non-small cell lung cancer.
@nl
P2093
P50
P1476
The EPHB6 receptor tyrosine ki ...... in non-small cell lung cancer.
@en
P2093
Alessandro Marra
Antje Hascher
Etmar Bulk
Moying Tang
Rainer Wiewroth
Ralf Metzger
Wolfgang E Berdel
P304
P356
10.1158/1078-0432.CCR-09-2000
P407
P577
2010-04-06T00:00:00Z